ES2570631T3 - Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal - Google Patents

Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal

Info

Publication number
ES2570631T3
ES2570631T3 ES08827168T ES08827168T ES2570631T3 ES 2570631 T3 ES2570631 T3 ES 2570631T3 ES 08827168 T ES08827168 T ES 08827168T ES 08827168 T ES08827168 T ES 08827168T ES 2570631 T3 ES2570631 T3 ES 2570631T3
Authority
ES
Spain
Prior art keywords
colorectal cancer
determination procedure
vitro diagnosis
apolipoprotein aii
aii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08827168T
Other languages
English (en)
Inventor
Yasemin Ataman-Önal
Jean-Philippe Charrier
Geneviève Choquet-Kastylevsky
Florence Poirier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Biomerieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux SA filed Critical Biomerieux SA
Application granted granted Critical
Publication of ES2570631T3 publication Critical patent/ES2570631T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides

Abstract

Procedimiento de diagnóstico in vitro del cáncer colorrectal por determinación de la disminución de la concentración del marcador apolipoproteína AII, con respecto a los valores de referencia determinados para los pacientes sanos, en una muestra biológica procedente de un paciente sospechoso de padecer cáncer colorrectal, estando dicha muestra distante del tumor.
ES08827168T 2007-07-19 2008-07-10 Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal Active ES2570631T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0705210A FR2919064B1 (fr) 2007-07-19 2007-07-19 Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
PCT/FR2008/051295 WO2009019370A2 (fr) 2007-07-19 2008-07-10 Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal

Publications (1)

Publication Number Publication Date
ES2570631T3 true ES2570631T3 (es) 2016-05-19

Family

ID=38657640

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08827168T Active ES2570631T3 (es) 2007-07-19 2008-07-10 Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal

Country Status (8)

Country Link
US (1) US8735078B2 (es)
EP (1) EP2167972B1 (es)
JP (1) JP5587773B2 (es)
CN (1) CN101779127B (es)
CA (1) CA2693658A1 (es)
ES (1) ES2570631T3 (es)
FR (1) FR2919064B1 (es)
WO (1) WO2009019370A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919062B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
ES2686336T3 (es) * 2011-04-21 2018-10-17 Biomerieux, Inc Procedimiento de detección de al menos un mecanismo de resistencia a los carbapenemos por espectrometría de masa
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
CA3189270A1 (en) * 2013-10-01 2015-04-09 Toray Industries, Inc. Method for detecting pancreatic tumor, antibodies, and kit for the detection of pancreatic tumor
CN104076158B (zh) * 2014-07-10 2016-08-17 深圳市新产业生物医学工程股份有限公司 一种用于测定高密度脂蛋白胆固醇的试剂盒
EP3252474B1 (en) * 2015-01-26 2020-10-21 Toray Industries, Inc. Method and kit for detecting biliary tract cancer
EP3267197B1 (en) 2015-03-02 2020-09-16 Toray Industries, Inc. Method and kit for the detection of pancreatic dysfunction
US11931966B2 (en) 2018-01-26 2024-03-19 Cellink Bioprinting Ab Systems and methods for optical assessments of bioink printability
KR20210047271A (ko) * 2018-10-25 2021-04-29 셀링크 에이비 시험관내 배양 및 이식을 위한 조직 구축물의 생리학적 3d 바이오프린팅을 위한 바이오검 및 식물성 검 히드로겔 바이오잉크
US11826951B2 (en) 2019-09-06 2023-11-28 Cellink Ab Temperature-controlled multi-material overprinting

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920484A1 (de) 1979-05-21 1980-12-04 Bosch Gmbh Robert Messeinrichtung mit magnetischem kreis zum messen eines gleichstroms
US4529931A (en) 1983-04-07 1985-07-16 Ford Motor Company Single-coil current measuring circuit
FR2581456B1 (fr) 1985-05-02 1987-07-17 Pasteur Institut Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
US5002870A (en) 1988-06-07 1991-03-26 California Institute For Medical Research Plastin isoforms and their use
US5360715A (en) 1988-06-07 1994-11-01 California Institute Of Technology Plastin isoforms and their uses
JP2816175B2 (ja) 1989-04-28 1998-10-27 三菱電機株式会社 直流電流測定装置
US5223789A (en) 1989-06-23 1993-06-29 Fuji Electric Co., Ltd. AC/DC current detecting method
JPH0464068A (ja) 1990-07-02 1992-02-28 Fuji Electric Co Ltd 直流電流検出方法
CA2054149A1 (en) 1990-10-29 1992-04-30 Eric Pringault Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals
US6291205B1 (en) 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
US6001632A (en) 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
DE19642472A1 (de) 1996-10-15 1998-04-16 Abb Research Ltd Flußkompensierter Stromsensor
CA2353546C (en) 1998-12-01 2009-05-19 Wrair Diagnosis of stage or aggressiveness of cancer
AU3479700A (en) 1999-02-22 2000-09-14 Incyte Pharmaceuticals, Inc. Genes associated with diseases of the colon
ES2244417T3 (es) 1999-04-09 2005-12-16 Rigshospitalet Inhibidor de tejido de metaloproteasa de matriz tipo-1 (timp-1) como un marcador de cancer.
WO2001022920A2 (en) 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
CN100416273C (zh) * 2000-08-21 2008-09-03 法国公立援助医院 采用生物化学标记物诊断纤维化疾病的方法
WO2002020731A2 (en) 2000-09-08 2002-03-14 Bayer Aktiengesellschaft Regulation of human protein disulfide isomerase-like enzyme
US20040110668A1 (en) 2000-10-02 2004-06-10 Burgess Christopher C. Nucleic acid sequences differentially expressed in cancer tissue
US20020160382A1 (en) 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
AU2002232407A1 (en) 2000-10-30 2002-05-15 Board Of Regents, The University Of Texas System Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof
US20030082533A1 (en) 2001-01-26 2003-05-01 Henry Yue Intelectin
WO2002074156A2 (en) 2001-02-02 2002-09-26 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
CN1396182A (zh) 2002-07-31 2003-02-12 陕西超英生物医学研究开发有限公司 人内皮生长因子受体2蛋白全人单克隆抗体及其制备方法
US20040157278A1 (en) 2002-12-13 2004-08-12 Bayer Corporation Detection methods using TIMP 1
KR100595364B1 (ko) * 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
US20040191782A1 (en) 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
JP4170139B2 (ja) * 2003-05-07 2008-10-22 財団法人癌研究会 血清アポリポタンパク質ａ−ｉｉ量変化の検出方法
WO2005015218A1 (en) 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
EP1649289B1 (en) * 2003-07-21 2008-10-22 Roche Diagnostics GmbH Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
WO2005015226A1 (en) 2003-08-08 2005-02-17 Roche Diagnostics Gmbh Use of protein t-plastin (plst) as a marker for colorectal cancer
US20050181398A1 (en) * 2004-01-16 2005-08-18 Fung Eric T. Specific detection of host response protein clusters
US7666583B2 (en) 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
US9086403B2 (en) 2004-06-03 2015-07-21 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US20090297523A1 (en) 2004-07-27 2009-12-03 Yale University Erm family binding agents and their use in diagnosis and treatment of proliferative conditions
AT500719B1 (de) 2004-09-08 2010-06-15 Red Bull Gmbh Chaperone als tumormarker
US7811772B2 (en) * 2005-01-06 2010-10-12 Eastern Virginia Medical School Apolipoprotein A-II isoform as a biomarker for prostate cancer
US20060192550A1 (en) 2005-02-25 2006-08-31 Sandquist David A Current sensor with magnetic toroid single frequency detection scheme
EP1724586A3 (en) 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
US8465929B2 (en) * 2005-06-24 2013-06-18 Vermillion, Inc. Biomarkers for ovarian cancer
WO2007020522A2 (en) 2005-08-18 2007-02-22 Zadec Aps Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
EP1775590A1 (en) 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
CN1967246A (zh) 2005-11-18 2007-05-23 上海中科新生命生物科技有限公司 酰化氨基酸水解酶1及其抗体检测肝癌的应用
EP1971359A2 (en) 2005-12-16 2008-09-24 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
WO2007140352A2 (en) 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers
WO2008021290A2 (en) 2006-08-09 2008-02-21 Homestead Clinical Corporation Organ-specific proteins and methods of their use
WO2008028968A2 (en) 2006-09-08 2008-03-13 Institut Gustave Roussy Compounds regulating calreticulin, kdel receptor and/or erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
WO2008036981A1 (en) 2006-09-22 2008-03-27 Dana-Farber Cancer Research, Inc. Methods for treating mica-related disorders
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal

Also Published As

Publication number Publication date
FR2919064A1 (fr) 2009-01-23
WO2009019370A3 (fr) 2009-04-09
CN101779127A (zh) 2010-07-14
EP2167972A2 (fr) 2010-03-31
WO2009019370A2 (fr) 2009-02-12
CA2693658A1 (fr) 2009-02-12
AU2008285559A1 (en) 2009-02-12
FR2919064B1 (fr) 2009-10-02
JP2010533855A (ja) 2010-10-28
US8735078B2 (en) 2014-05-27
JP5587773B2 (ja) 2014-09-10
EP2167972B1 (fr) 2016-02-17
US20100130375A1 (en) 2010-05-27
CN101779127B (zh) 2014-04-02

Similar Documents

Publication Publication Date Title
ES2570631T3 (es) Procedimiento de determinación de la apolipoproteína AII para el diagnóstico in vitro del cáncer colorrectal
ES2570632T3 (es) Procedimiento de determinación del inhibidor de elastasa de leucocito in vitro del cáncer colorrectal
AR083357A1 (es) Metodo para el diagnostico, pronostico y tratamiento de la metastasis de cancer de mama
MX2013002084A (es) Biomarcadores y metodos de tratamiento.
AR077901A1 (es) Anticuerpo anti- c-met y su uso para la deteccion y diagnostico del cancer
ES2570627T3 (es) Ensayo in vitro de Ezrina para el diagnóstico del cáncer colorrectal
BR112016007864A2 (pt) método para a prognose e tratamento de metástase de câncer
WO2010017515A3 (en) Breast cancer specific markers and methods of use
BR112015008255A2 (pt) método para o diagnóstico, prognóstico e tratamento de metástase de câncer de próstata
ES2654340T3 (es) Marcadores para cáncer endometrial
WO2012006589A3 (en) Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
EA200901550A1 (ru) Способы лечения, диагностирования и выявления ассоциированных с fgf21 нарушений
AR051524A1 (es) Seleccion de pacientes para una terapia con un inhibidor de her
ES2422739T3 (es) Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB
BR112014030750A2 (pt) Método para diagnóstico, prognóstico e tratamento da metástase do câncer pulmonar
EA201291044A1 (ru) Слитый белок robo1-fc и его применение в лечении опухолей
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
AR089067A1 (es) Biomarcadores en el plasma sanguineo para terapias de combinacion de bevacizumab destinadas al tratamiento del cancer de mama
BR112014031957A2 (pt) bag3 como soro bioquímico e marcador de tecido
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
CO6382138A2 (es) N-cadherina: blanco para diagnosis y terapia de cáncer
WO2011093675A3 (ko) 혈액으로부터 직접 폐암 진단 및 폐암의 서브타입 진단이 가능한 마커를 선별하는 시스템 생물학적 방법 및 이로부터 선별된 혈액으로부터 직접 폐암 진단 및 폐암 서브타입 진단이 가능한 마커
FR2919061B1 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
EA201290245A1 (ru) Радиоактивно меченные pde10 лиганды
ES2570609T3 (es) Método para someter a ensayo la aminoacilasa 1 para el diagnóstico in vitro del cáncer colorrectal